Immunotherapy Today

Immunotherapy News From Around The World

Immunotherapy

  • Why RemeGen (SEHK:9995) Is Up 13.1% After First HER2 ADC–Immunotherapy Approval in China - simplywall.st
  • Dr. Chokshi Reflects on Presentation Addressing Immune Checkpoint Inhibitor Toxicity Management - Cancer Nursing Today
  • Immunitas Presents Phase 1/2a Data Highlighting Anti-Tumor Activity of Novel Immunotherapy IMT-009 at AACR 2026 Annual Meeting - PR Newswire
  • Wungki Park: POLAR Study Provides Rationale for Precision Immunotherapy in Pancreatic Cancer - Oncodaily
  • Report: Merck’s blockbuster cancer drug topped $200,000 a year under Trump - International Consortium of Investigative Journalists - ICIJ
  • IRAKLIA Trial Validates Subcutaneous Isatuximab in Multiple Myeloma - Targeted Oncology
  • Study Identifies Why Multiple Myeloma May Return After Immunotherapy - Cure Today
  • Darlifarnib Plus Cabozantinib Active in ccRCC After Prior Cabozantinib - Targeted Oncology
  • Genomic Insights: How BRCA2 Inherited Variants Drive Drug Resistance - Targeted Oncology
  • Dostarlimab Delivers Durable Survival in RUBY Trial - Targeted Oncology
  • Parker Institute for Cancer Immunotherapy Network Shapes the Future Of Immunotherapy with Latest Research at AACR Annual Meeting 2026 - PR Newswire
  • Impact of Overall Survival Data on Immunotherapy Selection in Endometrial Cancer - Pharmacy Times
  • Unlocking the Secrets of Breast Cancer Mutations - Targeted Oncology
  • New roadmap links liver cancer biology to immunotherapy and precision medicine - News-Medical
  • Ankyra Therapeutics Announces Clinical Presentations on Novel IL-12 Anchored Immunotherapy at AACR 2026 - BioSpace
  • High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents - MedPage Today
  • Sequential or Concurrent Radiotherapy and Immunotherapy in Advanced Newly Diagnosed or Refractory NSCLC - The ASCO Post
  • Mayo Clinic researchers present advances in immunotherapy, biomarkers and tumor biology at AACR 2026 - Mayo Clinic News Network
  • ELEPHAS BIOSCIENCES AND MITHRL PAIR REAL-TIME TUMOR PROFILING WITH AGENTIC AI TO UNLOCK NEW IMMUNOTHERAPY RESPONSE INSIGHTS - PR Newswire
  • MajesTEC-3 Trial Results and Earlier-Line Treatment Evidence - Targeted Oncology
ImmunoTherapyToday.com is a global news aggregation platform dedicated to disseminating information about research and scientific discoveries from the transformative Immunotherapy scientific research community, as well as legal, business and regulatory news pertaining to the field.
Affiliated with CRISPRInsider.com
Skype interview, April 15, 2018
Oriana Sousa of Marinha Grande, Portugal was diagnosed in 2012 with an aggressive form of Small Cell Ovarian Cancer, and after several years of downturn and discouragement, was unexpectedly "cured" through immunotherapy. She has been in total remission for two years. This is her story.

Immunotherapy News from China

  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
    August 9, 2018
  • …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
    July 13, 2018
  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
    July 12, 2018
  • …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
    July 9, 2018
  • …Dosed in First-in-Human Clinical Study of Immunotherapy …
    July 3, 2018
  • JITC tumor and cancer immunotherapy papers collection
    June 29, 2018
  • Welcome to the submission|Journal for ImmunoTherapy of Cancer
    June 21, 2018
  • Immunotherapy shows promise for advanced lymphoma: study
    June 17, 2018
  • …from the Monotherapy Arm at the Phacilitate Immunotherapy …
    June 15, 2018
  • Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
    June 15, 2018
  • …to develop and commercialize hpv pre-cancer immunotherapy …
    May 31, 2018
  • Atara Biotherapeutics Expands T-Cell Immunotherapy …
    May 23, 2018
  • Inovio’s DNA Immunotherapy Demonstrates Immune Response …
    May 17, 2018
  • Immune Design Reports, Data Update for Lead Immunotherapy …
    April 29, 2018
  • …of U. S. firm providing immunotherapy for prostate cancer
    April 22, 2018
  • …numbers predict response to combination immunotherapy in …
    April 22, 2018
  • Immunotherapy shows promise in type 1 diabetes clinical trial…
    April 22, 2018

Contact

[recaptcha]

Copyright 2018 ImmunoTherapyToday.com